Frederick Robertson

Dr. Robertson is a seasoned corporate director and health care executive in the medical device, life science, and pharmaceutical industries. He has been a Venture Partner at Baird Capital since 2011 and retired from the anesthesiology faculty at the University of Wisconsin School of Medicine and Public Health in 2018. Previously, Robertson held the role of CEO and director of TomoTherapy Inc. before that company was acquired in 2011. Prior to joining TomoTherapy, Robertson served in a variety of roles in the medical industry, including president and CEO of GE Marquette Medical Systems and later as CEO of GE Medical Systems, as well as management positions with Marquette Medical Systems, including president and CEO. He served as a director of Lantheus Holdings from 2016-2021. He serves on the board of directors of the University of Wisconsin Foundation; the Morgridge Institute for Research; Alpha Source, Inc.; Ensodata, Inc.; Elucent, Inc.; and Zurex Pharma, Inc. Robertson received his M.B.A. from San Diego State University and earned his M.D. from University of Wisconsin Medical School.